Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma

OBJECTIVE: Lung cancer is one of the deadliest malignancies. The immune checkpoint-blockade (ICB) tumor therapy has led to striking improvement of long-term survival for some lung cancer patients. However, the response rate of immunotherapy is still low for lung cancer. Studying the tumor microenvir...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Min, Feng, Yuehua, Yue, Cuihua, Xu, Bin, Chen, Lujun, Jiang, Jingting, Lu, Binfeng, Zhu, Yibei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834175/
https://www.ncbi.nlm.nih.gov/pubmed/29499051
http://dx.doi.org/10.1371/journal.pone.0193428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834175/
https://www.ncbi.nlm.nih.gov/pubmed/29499051
http://dx.doi.org/10.1371/journal.pone.0193428

Ejemplares similares